TrialInvestigational new drugs2012

SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma.

Anthony B El-Khoueiry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.